溶瘤病毒递送CAR靶点实现实体瘤联合免疫治疗
该研究改造溶瘤牛痘病毒表达非信号型截短CD19(CD19t),使肿瘤细胞表面从头表达CD19,从而被CD19-CAR T细胞靶向。体外实验显示CD19-CAR T细胞对感染肿瘤细胞分泌细胞因子并发挥强效杀伤。多种小鼠肿瘤模型中,OV19t递送联合CD19-CAR T细胞给药促进肿瘤控制,并诱导内源性和过继转移T细胞浸润肿瘤。
要点
- 溶瘤病毒OV19t使肿瘤细胞表面从头表达CD19t,为CAR T细胞提供可靶向抗原。
- CD19-CAR T细胞对OV19t感染肿瘤细胞有强效细胞因子分泌和杀伤活性。
- 小鼠模型中OV19t联合CD19-CAR T细胞促进肿瘤控制并诱导T细胞浸润。
核心结论
- 溶瘤病毒递送CD19t可使实体瘤从头表达CAR靶点,联合CD19-CAR T细胞实现肿瘤控制。
研究设计与样本
- 工程化溶瘤牛痘病毒表达非信号型截短CD19(CD19t),体外共培养评估CD19-CAR T细胞反应。
- 使用多种小鼠肿瘤模型评估OV19t递送后CD19-CAR T细胞给药的抗肿瘤效果。
主要发现
- OV19t感染肿瘤细胞后在病毒介导的肿瘤裂解前于细胞表面产生从头CD19。
- 共培养的CD19-CAR T细胞分泌细胞因子并对感染肿瘤表现出强效细胞溶解活性。
- 多种小鼠肿瘤模型中,OV19t递送促进CD19-CAR T细胞给药后的肿瘤控制。
- OV19t诱导以肿瘤内内源性和过继转移T细胞浸润为特征的局部免疫。
- CAR T细胞介导的肿瘤杀伤诱导病毒从死亡肿瘤细胞释放,促进肿瘤CD19t表达传播。
临床怎么用
- 该策略利用溶瘤病毒在肿瘤局部递送CAR靶点,为缺乏肿瘤限制性和均一表达抗原的实体瘤提供联合免疫治疗思路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chimeric antigen receptor (CAR)-engineered T cell therapy for solid tumors is limited by the lack of both tumor-restricted and homogeneously expressed tumor antigens. Therefore, we engineered an oncolytic virus to express a nonsignaling, truncated CD19 (CD19t) protein for tumor-selective delivery, enabling targeting by CD19-CAR T cells. Infecting tumor cells with an oncolytic vaccinia virus coding for CD19t (OV19t) produced de novo CD19 at the cell surface before virus-mediated tumor lysis. Cocultured CD19-CAR T cells secreted cytokines and exhibited potent cytolytic activity against infected tumors. Using several mouse tumor models, delivery of OV19t promoted tumor control after CD19-CAR T cell administration. OV19t induced local immunity characterized by tumor infiltration of endogenous and adoptively transferred T cells. CAR T cell-mediated tumor killing also induced release of virus from dying tumor cells, which propagated tumor expression of CD19t. Our study features a combination immunotherapy approach using oncolytic viruses to promote de novo CAR T cell targeting of solid tumors.
引用
- Park AK, Fong Y, Kim SI, et al. Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors. Sci Transl Med. 2020. PMID: 32878978. doi:10.1126/scitranslmed.aaz1863
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。